Teleflex (TFX) Stock Overview
Designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
TFX Community Fair Values
Create NarrativeSee what 10 others think this stock is worth. Follow their fair value or set your own to get alerts.
Teleflex Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$116.67 |
| 52 Week High | US$249.91 |
| 52 Week Low | US$115.94 |
| Beta | 1.08 |
| 1 Month Change | -4.99% |
| 3 Month Change | -8.24% |
| 1 Year Change | -44.90% |
| 3 Year Change | -53.00% |
| 5 Year Change | -66.69% |
| Change since IPO | 31,042.56% |
Recent News & Updates
Investors Met With Slowing Returns on Capital At Teleflex (NYSE:TFX)
Jun 22
Teleflex's (NYSE:TFX) Dividend Will Be $0.34
May 16Recent updates
Investors Met With Slowing Returns on Capital At Teleflex (NYSE:TFX)
Jun 22Teleflex's (NYSE:TFX) Dividend Will Be $0.34
May 16Why Investors Shouldn't Be Surprised By Teleflex Incorporated's (NYSE:TFX) Low P/S
Mar 31Teleflex's (NYSE:TFX) Conservative Accounting Might Explain Soft Earnings
Mar 09Teleflex's Bold Transformation: Why I'm Skeptical On Value Creation
Mar 02Be Wary Of Teleflex (NYSE:TFX) And Its Returns On Capital
Feb 03Is Teleflex (NYSE:TFX) Using Too Much Debt?
Jan 14Should You Think About Buying Teleflex Incorporated (NYSE:TFX) Now?
Dec 27Teleflex Incorporated: Compelling Only On One Metric
Dec 11Why We're Not Concerned About Teleflex Incorporated's (NYSE:TFX) Share Price
Dec 09Here's What Analysts Are Forecasting For Teleflex Incorporated (NYSE:TFX) After Its Third-Quarter Results
Nov 02Does Teleflex (NYSE:TFX) Have A Healthy Balance Sheet?
Sep 30Returns On Capital At Teleflex (NYSE:TFX) Paint A Concerning Picture
Sep 14Market Participants Recognise Teleflex Incorporated's (NYSE:TFX) Earnings
Aug 29Teleflex Reinvesting In Growth, But Valuation Isn't That Compelling
Aug 26
Innovation And Critical Acquisitions Propel Revenue Recovery
Expansion in geographic markets and new product introductions suggest ongoing innovation and revenue growth opportunities.Is Teleflex Incorporated (NYSE:TFX) Potentially Undervalued?
Jul 29Teleflex: Compelling, Despite Some Operational Hiccups
May 06Teleflex Shares Hit Hard As Growth Concerns Stack Up
Oct 13Shareholder Returns
| TFX | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -1.4% | -1.4% | 0.4% |
| 1Y | -44.9% | 10.3% | 12.5% |
Return vs Industry: TFX underperformed the US Medical Equipment industry which returned 10.8% over the past year.
Return vs Market: TFX underperformed the US Market which returned 13.7% over the past year.
Price Volatility
| TFX volatility | |
|---|---|
| TFX Average Weekly Movement | 4.9% |
| Medical Equipment Industry Average Movement | 8.3% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 17.3% |
| 10% least volatile stocks in US Market | 3.7% |
Stable Share Price: TFX has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: TFX's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1943 | 14,100 | Liam Kelly | www.teleflex.com |
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also offers interventional products, including various coronary catheters, structural heart support devices, peripheral intervention products, and mechanical circulatory support platform; and Arrow branded intra-aortic balloon pumps and catheters, Guideliner, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
Teleflex Incorporated Fundamentals Summary
| TFX fundamental statistics | |
|---|---|
| Market cap | US$5.30b |
| Earnings (TTM) | US$149.53m |
| Revenue (TTM) | US$3.01b |
Is TFX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TFX income statement (TTM) | |
|---|---|
| Revenue | US$3.01b |
| Cost of Revenue | US$1.32b |
| Gross Profit | US$1.69b |
| Other Expenses | US$1.54b |
| Earnings | US$149.53m |
Last Reported Earnings
Mar 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.38 |
| Gross Margin | 55.98% |
| Net Profit Margin | 4.97% |
| Debt/Equity Ratio | 47.1% |
How did TFX perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/07 03:18 |
| End of Day Share Price | 2025/07/07 00:00 |
| Earnings | 2025/03/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Teleflex Incorporated is covered by 35 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ishan Majumdar | Baptista Research |
| Matthew Taylor | Barclays |
| Craig Bijou | BofA Global Research |